Syngene International Limited (SYNGENE) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.010x

Based on the latest financial reports, Syngene International Limited (SYNGENE) has a cash flow conversion efficiency ratio of -0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-451.00 Million ≈ $-4.88 Million USD) by net assets (Rs47.35 Billion ≈ $512.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Syngene International Limited - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Syngene International Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SYNGENE total liabilities for a breakdown of total debt and financial obligations.

Syngene International Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Syngene International Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SIRIUSPOINT LTD. DL-10 F:3XPA	N/A
Nanjing Gaoke Co Ltd SHG:600064	0.010x
Huizhou Speed Wireless Technology Co Ltd SHE:300322	-0.085x
Suzhou Shijia Science & Technology Inc SHE:002796	-0.031x
Sino Geophysical SHE:300191	0.020x
Polaris Bay Group Co Ltd SHG:600155	-0.207x
Jiugui Liquor Co Ltd SHE:000799	-0.028x
Schiehallion Fund Ltd LSE:MNTN	-0.004x

Annual Cash Flow Conversion Efficiency for Syngene International Limited (2010–2025)

The table below shows the annual cash flow conversion efficiency of Syngene International Limited from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see SYNGENE stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs47.27 Billion ≈ $511.19 Million	Rs11.68 Billion ≈ $126.27 Million	0.247x	+0.93%
2024-03-31	Rs42.58 Billion ≈ $460.46 Million	Rs10.42 Billion ≈ $112.70 Million	0.245x	+5.62%
2023-03-31	Rs36.18 Billion ≈ $391.27 Million	Rs8.38 Billion ≈ $90.67 Million	0.232x	+31.61%
2022-03-31	Rs32.98 Billion ≈ $356.62 Million	Rs5.81 Billion ≈ $62.79 Million	0.176x	-29.16%
2021-03-31	Rs28.21 Billion ≈ $305.12 Million	Rs7.01 Billion ≈ $75.83 Million	0.249x	-20.14%
2020-03-31	Rs21.76 Billion ≈ $235.30 Million	Rs6.77 Billion ≈ $73.23 Million	0.311x	-2.83%
2019-03-31	Rs19.68 Billion ≈ $212.87 Million	Rs6.30 Billion ≈ $68.18 Million	0.320x	+23.48%
2018-03-31	Rs17.20 Billion ≈ $186.05 Million	Rs4.46 Billion ≈ $48.25 Million	0.259x	-7.85%
2017-03-31	Rs14.13 Billion ≈ $152.82 Million	Rs3.98 Billion ≈ $43.01 Million	0.281x	-5.15%
2016-03-31	Rs10.53 Billion ≈ $113.86 Million	Rs3.12 Billion ≈ $33.78 Million	0.297x	+1255.19%
2015-03-31	Rs8.45 Billion ≈ $91.37 Million	Rs185.00 Million ≈ $2.00 Million	0.022x	-95.18%
2014-03-31	Rs6.59 Billion ≈ $71.30 Million	Rs3.00 Billion ≈ $32.39 Million	0.454x	+127.62%
2013-03-31	Rs5.19 Billion ≈ $56.08 Million	Rs1.03 Billion ≈ $11.19 Million	0.200x	-51.53%
2012-03-31	Rs2.97 Billion ≈ $32.10 Million	Rs1.22 Billion ≈ $13.22 Million	0.412x	+13.87%
2011-03-31	Rs2.21 Billion ≈ $23.87 Million	Rs798.00 Million ≈ $8.63 Million	0.362x	-14.05%
2010-03-31	Rs1.94 Billion ≈ $20.93 Million	Rs814.00 Million ≈ $8.80 Million	0.421x	--

About Syngene International Limited

NSE:SYNGENE India Diagnostics & Research

Market Cap

$2.03 Billion

Rs187.86 Billion INR

Market Cap Rank

#6193 Global

#271 in India

Share Price

Rs467.65

Change (1 day)

+8.21%

52-Week Range

Rs389.90 - Rs722.05

All Time High

Rs947.80